| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.13e-08 | 188 | 56 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | insulin-like growth factor II binding | 2.14e-04 | 8 | 56 | 2 | GO:0031995 | |
| GeneOntologyMolecularFunction | palmitoyl-(protein) hydrolase activity | 5.91e-04 | 13 | 56 | 2 | GO:0008474 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 5.91e-04 | 13 | 56 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | palmitoyl hydrolase activity | 6.88e-04 | 14 | 56 | 2 | GO:0098599 | |
| GeneOntologyMolecularFunction | structural molecule activity | 7.73e-04 | 891 | 56 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | growth factor binding | 9.60e-04 | 156 | 56 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.28e-03 | 19 | 56 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | integrin binding | 1.47e-03 | 175 | 56 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 1.72e-03 | 22 | 56 | 2 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 1.72e-03 | 22 | 56 | 2 | GO:0003756 | |
| GeneOntologyBiologicalProcess | keratinization | 1.61e-07 | 87 | 58 | 6 | GO:0031424 | |
| GeneOntologyBiologicalProcess | skin development | 9.15e-07 | 373 | 58 | 9 | GO:0043588 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.49e-05 | 189 | 58 | 6 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epidermis development | 4.22e-05 | 461 | 58 | 8 | GO:0008544 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to microtubule | 7.73e-05 | 5 | 58 | 2 | GO:1902817 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to microtubule | 7.73e-05 | 5 | 58 | 2 | GO:1902816 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.43e-04 | 284 | 58 | 6 | GO:0009913 | |
| GeneOntologyBiologicalProcess | epithelium development | NTN4 FRAS1 CCN1 CNFN NTRK1 LCE5A LAMA5 BMPER KRT38 LCE2D LCE2C LCE3B LCE7A | 1.76e-04 | 1469 | 58 | 13 | GO:0060429 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A4 CCN6 LRIG3 CRELD1 NTN4 LAMB4 FRAS1 FCGBP CCN1 TIMP1 LAMA5 BMPER SSPOP PLSCR1 | 1.73e-09 | 656 | 57 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A4 CCN6 LRIG3 CRELD1 NTN4 LAMB4 FRAS1 FCGBP CCN1 TIMP1 LAMA5 BMPER SSPOP PLSCR1 | 1.80e-09 | 658 | 57 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | intermediate filament | KRTAP5-9 KRTAP17-1 KRT38 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.03e-08 | 227 | 57 | 9 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP5-9 KRTAP17-1 KRT38 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.66e-08 | 263 | 57 | 9 | GO:0045111 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A4 CRELD1 NTN4 LAMB4 FRAS1 CCN1 TIMP1 LAMA5 BMPER SSPOP PLSCR1 | 1.61e-07 | 530 | 57 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | keratin filament | KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 2.56e-07 | 97 | 57 | 6 | GO:0045095 |
| GeneOntologyCellularComponent | basement membrane | 9.94e-07 | 122 | 57 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 1.09e-04 | 6 | 57 | 2 | GO:0098944 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP5-9 MT3 KRTAP17-1 KRT38 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.41e-04 | 899 | 57 | 10 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP5-9 COL4A4 MT3 KRTAP17-1 KRT38 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.12e-04 | 1187 | 57 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | laminin complex | 3.24e-04 | 10 | 57 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 3.95e-04 | 11 | 57 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | postsynaptic recycling endosome | 5.59e-04 | 13 | 57 | 2 | GO:0098837 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP5-9 MT3 KRTAP17-1 KRT38 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.20e-03 | 1179 | 57 | 10 | GO:0099512 |
| GeneOntologyCellularComponent | postsynaptic endosome | 2.28e-03 | 26 | 57 | 2 | GO:0098845 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 3.55e-03 | 112 | 57 | 3 | GO:0055038 | |
| HumanPheno | Abnormal lumbar spine morphology | 3.16e-05 | 34 | 10 | 3 | HP:0100712 | |
| Domain | VWC | 1.52e-13 | 38 | 55 | 8 | SM00214 | |
| Domain | VWF_dom | 3.63e-13 | 42 | 55 | 8 | IPR001007 | |
| Domain | Growth_fac_rcpt_ | CCN6 NELL1 CRELD1 NTN4 FRAS1 IGFBP2 IGFBP4 CCN1 CRELD2 LAMA5 VWCE | 8.43e-13 | 156 | 55 | 11 | IPR009030 |
| Domain | VWFC_1 | 1.01e-11 | 36 | 55 | 7 | PS01208 | |
| Domain | VWC_out | 1.30e-11 | 19 | 55 | 6 | SM00215 | |
| Domain | VWFC_2 | 1.52e-11 | 38 | 55 | 7 | PS50184 | |
| Domain | VWC | 1.76e-10 | 28 | 55 | 6 | PF00093 | |
| Domain | KAP | KRTAP5-9 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.46e-10 | 58 | 55 | 7 | IPR002494 |
| Domain | Keratin_B2_2 | KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.49e-09 | 39 | 55 | 6 | PF13885 |
| Domain | EGF_1 | 3.22e-09 | 255 | 55 | 10 | PS00022 | |
| Domain | Insulin_GF-bd_Cys-rich_CS | 2.19e-08 | 11 | 55 | 4 | IPR017891 | |
| Domain | IGFBP_N_1 | 3.27e-08 | 12 | 55 | 4 | PS00222 | |
| Domain | Unchr_dom_Cys-rich | 4.72e-08 | 13 | 55 | 4 | IPR014853 | |
| Domain | C8 | 4.72e-08 | 13 | 55 | 4 | SM00832 | |
| Domain | EGF-like_CS | 6.42e-08 | 261 | 55 | 9 | IPR013032 | |
| Domain | TIL_dom | 6.59e-08 | 14 | 55 | 4 | IPR002919 | |
| Domain | EGF_2 | 7.32e-08 | 265 | 55 | 9 | PS01186 | |
| Domain | Laminin_EGF | 8.57e-08 | 38 | 55 | 5 | IPR002049 | |
| Domain | Keratin_B2 | 1.12e-07 | 40 | 55 | 5 | PF01500 | |
| Domain | VWFD | 1.19e-07 | 16 | 55 | 4 | PS51233 | |
| Domain | VWD | 1.19e-07 | 16 | 55 | 4 | SM00216 | |
| Domain | VWF_type-D | 1.19e-07 | 16 | 55 | 4 | IPR001846 | |
| Domain | VWD | 1.19e-07 | 16 | 55 | 4 | PF00094 | |
| Domain | LCE | 1.56e-07 | 17 | 55 | 4 | PF14672 | |
| Domain | LCE | 1.56e-07 | 17 | 55 | 4 | IPR028205 | |
| Domain | IB | 2.00e-07 | 18 | 55 | 4 | SM00121 | |
| Domain | IGFBP_N_2 | 3.15e-07 | 20 | 55 | 4 | PS51323 | |
| Domain | IGFBP-like | 3.15e-07 | 20 | 55 | 4 | IPR000867 | |
| Domain | IGFBP | 3.15e-07 | 20 | 55 | 4 | PF00219 | |
| Domain | EGF | 4.08e-07 | 235 | 55 | 8 | SM00181 | |
| Domain | EGF-like_dom | 6.32e-07 | 249 | 55 | 8 | IPR000742 | |
| Domain | SPRR/LCE | 1.31e-06 | 28 | 55 | 4 | IPR026075 | |
| Domain | Laminin_EGF | 3.29e-06 | 35 | 55 | 4 | PF00053 | |
| Domain | TIL | 5.22e-06 | 12 | 55 | 3 | PF01826 | |
| Domain | C8 | 5.22e-06 | 12 | 55 | 3 | PF08742 | |
| Domain | EGF_Ca-bd_CS | 9.65e-06 | 97 | 55 | 5 | IPR018097 | |
| Domain | EGF_CA | 1.07e-05 | 99 | 55 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.12e-05 | 100 | 55 | 5 | PS00010 | |
| Domain | LAMININ_NTER | 1.32e-05 | 16 | 55 | 3 | PS51117 | |
| Domain | Laminin_N | 1.32e-05 | 16 | 55 | 3 | PF00055 | |
| Domain | Laminin_N | 1.32e-05 | 16 | 55 | 3 | IPR008211 | |
| Domain | LamNT | 1.32e-05 | 16 | 55 | 3 | SM00136 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.49e-05 | 106 | 55 | 5 | IPR000152 | |
| Domain | Furin_repeat | 1.91e-05 | 18 | 55 | 3 | IPR006212 | |
| Domain | CTCK_1 | 1.91e-05 | 18 | 55 | 3 | PS01185 | |
| Domain | FU | 1.91e-05 | 18 | 55 | 3 | SM00261 | |
| Domain | EGF_CA | 2.93e-05 | 122 | 55 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.17e-05 | 124 | 55 | 5 | IPR001881 | |
| Domain | Cys_knot_C | 5.31e-05 | 25 | 55 | 3 | IPR006207 | |
| Domain | CTCK_2 | 5.31e-05 | 25 | 55 | 3 | PS01225 | |
| Domain | EGF_3 | 6.45e-05 | 235 | 55 | 6 | PS50026 | |
| Domain | IGFBP_CNN | 8.47e-05 | 5 | 55 | 2 | IPR012395 | |
| Domain | EGF_LAM_2 | 9.27e-05 | 30 | 55 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 9.27e-05 | 30 | 55 | 3 | PS01248 | |
| Domain | EGF_CA | 1.19e-04 | 86 | 55 | 4 | PF07645 | |
| Domain | IGFBP1-6 | 1.27e-04 | 6 | 55 | 2 | IPR009168 | |
| Domain | IGFBP_1-6_chordata | 1.27e-04 | 6 | 55 | 2 | IPR022321 | |
| Domain | EGF_Lam | 1.48e-04 | 35 | 55 | 3 | SM00180 | |
| Domain | DUF3456 | 1.77e-04 | 7 | 55 | 2 | IPR021852 | |
| Domain | DUF3456 | 1.77e-04 | 7 | 55 | 2 | PF11938 | |
| Domain | Hydrolase_4 | 3.02e-04 | 9 | 55 | 2 | PF12146 | |
| Domain | Hydrolase_4 | 3.02e-04 | 9 | 55 | 2 | IPR022742 | |
| Domain | EGF_extracell | 7.34e-04 | 60 | 55 | 3 | IPR013111 | |
| Domain | EGF_2 | 7.34e-04 | 60 | 55 | 3 | PF07974 | |
| Domain | TSP_1 | 8.47e-04 | 63 | 55 | 3 | PF00090 | |
| Domain | Glyco_hormone_CN | 8.72e-04 | 15 | 55 | 2 | IPR006208 | |
| Domain | Cys_knot | 8.72e-04 | 15 | 55 | 2 | PF00007 | |
| Domain | TSP1 | 9.28e-04 | 65 | 55 | 3 | SM00209 | |
| Domain | TSP1_rpt | 9.28e-04 | 65 | 55 | 3 | IPR000884 | |
| Domain | TSP1 | 9.28e-04 | 65 | 55 | 3 | PS50092 | |
| Domain | Thyroglobulin_1 | 1.13e-03 | 17 | 55 | 2 | PF00086 | |
| Domain | TY | 1.13e-03 | 17 | 55 | 2 | SM00211 | |
| Domain | - | 1.13e-03 | 17 | 55 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_1 | 1.13e-03 | 17 | 55 | 2 | PS00484 | |
| Domain | THYROGLOBULIN_1_2 | 1.13e-03 | 17 | 55 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 1.13e-03 | 17 | 55 | 2 | IPR000716 | |
| Domain | CT | 1.89e-03 | 22 | 55 | 2 | SM00041 | |
| Domain | Netrin_domain | 2.07e-03 | 23 | 55 | 2 | IPR001134 | |
| Domain | NTR | 2.07e-03 | 23 | 55 | 2 | PS50189 | |
| Domain | Cys-rich_flank_reg_C | 2.37e-03 | 90 | 55 | 3 | IPR000483 | |
| Domain | LRRCT | 2.37e-03 | 90 | 55 | 3 | SM00082 | |
| Domain | TIMP-like_OB-fold | 2.64e-03 | 26 | 55 | 2 | IPR008993 | |
| Domain | Galactose-bd-like | 2.68e-03 | 94 | 55 | 3 | IPR008979 | |
| Domain | LRRCT | 3.99e-03 | 32 | 55 | 2 | PF01463 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP5-9 LCE5A KRTAP17-1 KRT38 KRTAP10-1 LCE2D LCE2C KRTAP10-2 LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 2.29e-14 | 217 | 41 | 13 | M27640 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.22e-06 | 84 | 41 | 5 | M7098 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 4.87e-06 | 153 | 41 | 6 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP5-9 COL4A4 NTN4 LCE5A KRTAP17-1 KRT38 KRTAP10-1 LCE2D LCE2C KRTAP10-2 LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 5.79e-06 | 1432 | 41 | 15 | M509 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.42e-05 | 129 | 41 | 5 | M27649 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A4 NTN4 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 8.28e-05 | 502 | 41 | 8 | MM14537 |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 3.96e-04 | 120 | 41 | 4 | MM14982 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.09e-04 | 339 | 41 | 6 | M39736 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 4.49e-04 | 124 | 41 | 4 | M27285 | |
| Pathway | BIOCARTA_GHRELIN_PATHWAY | 6.31e-04 | 13 | 41 | 2 | M22016 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.63e-04 | 59 | 41 | 3 | M27218 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.09e-03 | 17 | 41 | 2 | M212 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.39e-03 | 76 | 41 | 3 | M27219 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.69e-03 | 300 | 41 | 5 | M610 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.85e-03 | 84 | 41 | 3 | M3228 | |
| Pubmed | KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.45e-13 | 16 | 59 | 6 | 15028290 | |
| Pubmed | 2.44e-09 | 11 | 59 | 4 | 14962103 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP5-9 LCE5A KRT38 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 8.04e-09 | 630 | 59 | 11 | 36949045 |
| Pubmed | 1.34e-08 | 16 | 59 | 4 | 17410201 | ||
| Pubmed | 5.34e-08 | 22 | 59 | 4 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 6.45e-08 | 23 | 59 | 4 | 11698679 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.42e-07 | 79 | 59 | 5 | 18757743 | |
| Pubmed | 6.52e-07 | 40 | 59 | 4 | 12359730 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12137942 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19956906 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28179448 | ||
| Pubmed | [Expressions of Cyr61 and WISP-3 in non-small cell lung cancer and its clinical significance]. | 2.83e-06 | 2 | 59 | 2 | 21159247 | |
| Pubmed | KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 5.10e-06 | 258 | 59 | 6 | 10830953 | |
| Pubmed | 5.95e-06 | 69 | 59 | 4 | 18721477 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 21628462 | ||
| Pubmed | Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. | 8.48e-06 | 3 | 59 | 2 | 7525256 | |
| Pubmed | Insulin-like growth factor-II and its binding proteins in placental development. | 8.48e-06 | 3 | 59 | 2 | 1380437 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 17071580 | ||
| Pubmed | Anatomy of the human ovarian insulin-like growth factor system. | 8.48e-06 | 3 | 59 | 2 | 7680905 | |
| Pubmed | 1.22e-05 | 175 | 59 | 5 | 28071719 | ||
| Pubmed | 1.32e-05 | 27 | 59 | 3 | 24391734 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 10888943 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 26701913 | ||
| Pubmed | The mouse intraovarian insulin-like growth factor I system: departures from the rat paradigm. | 1.69e-05 | 4 | 59 | 2 | 9275078 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 9408744 | ||
| Pubmed | 2.62e-05 | 205 | 59 | 5 | 20436479 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 15978004 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 7687569 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 17255210 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 28521134 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A4 CRELD1 FRAS1 IGFBP4 CCN1 TIMP1 CRELD2 LAMA5 BMPER PLSCR1 | 3.13e-05 | 1201 | 59 | 10 | 35696571 |
| Pubmed | Insulin-like growth factor binding proteins are transcribed by preimplantation mouse embryos. | 4.23e-05 | 6 | 59 | 2 | 7511095 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 7684980 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 10579362 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 8923818 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 9093203 | ||
| Pubmed | Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). | 4.23e-05 | 6 | 59 | 2 | 26498181 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 8635876 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 15661050 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 12933651 | ||
| Pubmed | IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung. | 4.23e-05 | 6 | 59 | 2 | 7545402 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 7510770 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 7679139 | ||
| Pubmed | Insulin-like growth factor binding proteins in the human adrenal gland. | 4.23e-05 | 6 | 59 | 2 | 7511544 | |
| Pubmed | Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. | 4.23e-05 | 6 | 59 | 2 | 10744620 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 10976924 | ||
| Pubmed | cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins. | 4.23e-05 | 6 | 59 | 2 | 7529732 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 4.47e-05 | 560 | 59 | 7 | 21653829 | |
| Pubmed | CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins. | 5.91e-05 | 7 | 59 | 2 | 36804407 | |
| Pubmed | Transferrin is an insulin-like growth factor-binding protein-3 binding protein. | 5.91e-05 | 7 | 59 | 2 | 11297622 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 27307232 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.48e-05 | 248 | 59 | 5 | 24006456 | |
| Pubmed | Common variants in the trichohyalin gene are associated with straight hair in Europeans. | 7.87e-05 | 8 | 59 | 2 | 19896111 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 10407151 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 16338473 | ||
| Pubmed | Systematic association mapping identifies NELL1 as a novel IBD disease gene. | 7.87e-05 | 8 | 59 | 2 | 17684544 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 16047381 | ||
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 7.87e-05 | 8 | 59 | 2 | 12766770 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 22688304 | ||
| Pubmed | Gene expression of the insulin-like growth factor system during mouse kidney development. | 1.01e-04 | 9 | 59 | 2 | 9324049 | |
| Pubmed | Expression of IGF ligand and receptor genes during preimplantation mammalian development. | 1.01e-04 | 9 | 59 | 2 | 8398121 | |
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 10880400 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 9685224 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 10502456 | ||
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 12855770 | ||
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 15623520 | ||
| Pubmed | 1.54e-04 | 11 | 59 | 2 | 22315402 | ||
| Pubmed | Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. | 1.54e-04 | 11 | 59 | 2 | 11435469 | |
| Pubmed | 1.54e-04 | 11 | 59 | 2 | 18367596 | ||
| Pubmed | IGFs increase enamel formation by inducing expression of enamel mineralizing specific genes. | 1.54e-04 | 11 | 59 | 2 | 15721138 | |
| Pubmed | 1.54e-04 | 11 | 59 | 2 | 7750499 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 1.54e-04 | 11 | 59 | 2 | 9731539 | |
| Pubmed | 1.63e-04 | 62 | 59 | 3 | 23088713 | ||
| Pubmed | Protein-protein interaction panel using mouse full-length cDNAs. | 1.65e-04 | 161 | 59 | 4 | 11591653 | |
| Pubmed | 1.90e-04 | 167 | 59 | 4 | 22159717 | ||
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 12682087 | ||
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 18597638 | ||
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 35741102 | ||
| Pubmed | The integrity of cholinergic basal forebrain neurons depends on expression of Nkx2-1. | 2.18e-04 | 13 | 59 | 2 | 22098391 | |
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 21048141 | ||
| Pubmed | Expression of insulin-like growth factor binding proteins during mouse cochlear development. | 2.54e-04 | 14 | 59 | 2 | 23813480 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 2.55e-04 | 742 | 59 | 7 | 26871637 | |
| Pubmed | 2.87e-04 | 75 | 59 | 3 | 20637190 | ||
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 10625553 | ||
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 9264260 | ||
| Pubmed | 3.34e-04 | 16 | 59 | 2 | 19627984 | ||
| Pubmed | 3.34e-04 | 16 | 59 | 2 | 25211233 | ||
| Pubmed | 4.25e-04 | 18 | 59 | 2 | 20810604 | ||
| Pubmed | 4.25e-04 | 18 | 59 | 2 | 14730302 | ||
| Pubmed | 4.25e-04 | 18 | 59 | 2 | 11311202 | ||
| Pubmed | 4.75e-04 | 19 | 59 | 2 | 10393115 | ||
| Pubmed | Widespread macromolecular interaction perturbations in human genetic disorders. | 4.89e-04 | 590 | 59 | 6 | 25910212 | |
| Pubmed | Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. | 5.27e-04 | 20 | 59 | 2 | 26033091 | |
| Pubmed | 5.27e-04 | 20 | 59 | 2 | 19590686 | ||
| Pubmed | Coup-TF1 and Coup-TF2 control subtype and laminar identity of MGE-derived neocortical interneurons. | 5.82e-04 | 21 | 59 | 2 | 28694260 | |
| Pubmed | 5.82e-04 | 21 | 59 | 2 | 27856617 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 6.87e-04 | 101 | 59 | 3 | 23382219 | |
| Pubmed | High-density polymorphisms analysis of 23 candidate genes for association with bone mineral density. | 7.00e-04 | 23 | 59 | 2 | 20654748 | |
| Pubmed | 7.62e-04 | 24 | 59 | 2 | 31062503 | ||
| Pubmed | Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. | 7.62e-04 | 24 | 59 | 2 | 21323541 | |
| Interaction | HOXA1 interactions | KRTAP5-9 NELL1 CRELD1 SPRY3 NTN4 TCF19 CNFN LCE5A CRELD2 LAMA5 C11orf16 VWCE PLSCR1 KRT38 KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-8 | 3.43e-21 | 356 | 57 | 20 | int:HOXA1 |
| Interaction | LCE2B interactions | KRTAP5-9 SPRY3 LCE5A KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 4.64e-18 | 81 | 57 | 12 | int:LCE2B |
| Interaction | LCE1B interactions | KRTAP5-9 SPRY3 LCE5A KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 8.57e-18 | 85 | 57 | 12 | int:LCE1B |
| Interaction | KRTAP4-11 interactions | KRTAP5-9 LCE5A KRTAP17-1 PLSCR1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 2.33e-17 | 92 | 57 | 12 | int:KRTAP4-11 |
| Interaction | KRTAP5-6 interactions | KRTAP5-9 LCE5A KRTAP17-1 PLSCR1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.05e-17 | 94 | 57 | 12 | int:KRTAP5-6 |
| Interaction | LCE1E interactions | KRTAP5-9 LCE5A KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 4.51e-17 | 68 | 57 | 11 | int:LCE1E |
| Interaction | LCE2D interactions | KRTAP5-9 LCE5A KRTAP17-1 PLSCR1 KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.21e-16 | 74 | 57 | 11 | int:LCE2D |
| Interaction | LCE4A interactions | KRTAP5-9 LCE5A KRTAP17-1 PLSCR1 KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.01e-16 | 80 | 57 | 11 | int:LCE4A |
| Interaction | KRTAP4-4 interactions | KRTAP5-9 LCE5A KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.47e-16 | 81 | 57 | 11 | int:KRTAP4-4 |
| Interaction | LCE1A interactions | KRTAP5-9 SPRY3 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 5.28e-16 | 84 | 57 | 11 | int:LCE1A |
| Interaction | KRTAP5-2 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.37e-15 | 62 | 57 | 10 | int:KRTAP5-2 |
| Interaction | LCE1F interactions | KRTAP5-9 SPRY3 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.50e-15 | 92 | 57 | 11 | int:LCE1F |
| Interaction | LCE3C interactions | KRTAP5-9 LCE5A KRTAP17-1 PLSCR1 KRTAP10-1 LCE2D KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.12e-15 | 67 | 57 | 10 | int:LCE3C |
| Interaction | KRTAP9-8 interactions | KRTAP5-9 LCE5A KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.90e-15 | 100 | 57 | 11 | int:KRTAP9-8 |
| Interaction | LCE2A interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 4.26e-15 | 69 | 57 | 10 | int:LCE2A |
| Interaction | LCE1D interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 4.96e-15 | 70 | 57 | 10 | int:LCE1D |
| Interaction | LCE3B interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 6.07e-15 | 46 | 57 | 9 | int:LCE3B |
| Interaction | LCE3D interactions | KRTAP5-9 SPRY3 KRTAP17-1 KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 7.72e-15 | 73 | 57 | 10 | int:LCE3D |
| Interaction | LCE3A interactions | KRTAP5-9 SPRY3 KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.18e-14 | 76 | 57 | 10 | int:LCE3A |
| Interaction | SMCP interactions | KRTAP5-9 LCE5A PLSCR1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.77e-14 | 79 | 57 | 10 | int:SMCP |
| Interaction | CATSPER1 interactions | KRTAP5-9 SPRY3 LCE5A KRTAP17-1 C11orf16 PLSCR1 KRTAP10-1 LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-8 | 5.29e-14 | 126 | 57 | 11 | int:CATSPER1 |
| Interaction | LCE2C interactions | KRTAP5-9 LCE5A KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-7 KRTAP10-6 KRTAP10-8 | 5.43e-14 | 88 | 57 | 10 | int:LCE2C |
| Interaction | LCE5A interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 6.86e-14 | 90 | 57 | 10 | int:LCE5A |
| Interaction | KRTAP4-2 interactions | KRTAP5-9 LCE5A PLSCR1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 8.90e-14 | 132 | 57 | 11 | int:KRTAP4-2 |
| Interaction | KRTAP5-4 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.26e-13 | 63 | 57 | 9 | int:KRTAP5-4 |
| Interaction | KRTAP10-11 interactions | KRTAP5-9 LCE5A PLSCR1 KRTAP10-1 LCE2D LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.46e-13 | 64 | 57 | 9 | int:KRTAP10-11 |
| Interaction | KRTAP5-11 interactions | KRTAP5-9 LCE5A KRTAP17-1 KRTAP10-1 LCE2C LCE3B KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.95e-13 | 66 | 57 | 9 | int:KRTAP5-11 |
| Interaction | KRTAP5-3 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.95e-13 | 66 | 57 | 9 | int:KRTAP5-3 |
| Interaction | KRTAP9-2 interactions | KRTAP5-9 LCE5A KRTAP17-1 PLSCR1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 3.42e-13 | 149 | 57 | 11 | int:KRTAP9-2 |
| Interaction | KRTAP5-9 interactions | KRTAP5-9 ABHD17A NTN4 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.74e-13 | 203 | 57 | 12 | int:KRTAP5-9 |
| Interaction | KRTAP4-5 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-7 KRTAP10-6 KRTAP10-8 | 7.36e-13 | 76 | 57 | 9 | int:KRTAP4-5 |
| Interaction | KRTAP4-12 interactions | KRTAP5-9 LCE5A DLK2 PLSCR1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 8.05e-13 | 161 | 57 | 11 | int:KRTAP4-12 |
| Interaction | LCE1C interactions | KRTAP5-9 NTN4 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-8 | 8.31e-13 | 77 | 57 | 9 | int:LCE1C |
| Interaction | KRTAP10-1 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.50e-11 | 153 | 57 | 10 | int:KRTAP10-1 |
| Interaction | KRTAP10-5 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 2.35e-11 | 160 | 57 | 10 | int:KRTAP10-5 |
| Interaction | SPRY1 interactions | KRTAP5-9 SPRY3 LCE5A KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-8 | 2.42e-11 | 111 | 57 | 9 | int:SPRY1 |
| Interaction | MOBP interactions | 3.80e-11 | 23 | 57 | 6 | int:MOBP | |
| Interaction | SPATA3 interactions | 5.05e-11 | 24 | 57 | 6 | int:SPATA3 | |
| Interaction | POU4F2 interactions | KRTAP5-9 NTRK1 LCE5A KRT38 KRTAP10-1 LCE2C KRTAP10-11 KRTAP10-8 | 8.22e-11 | 83 | 57 | 8 | int:POU4F2 |
| Interaction | KRTAP9-3 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.97e-10 | 140 | 57 | 9 | int:KRTAP9-3 |
| Interaction | LCE3E interactions | KRTAP5-9 SPRY3 KRTAP10-1 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 3.40e-10 | 60 | 57 | 7 | int:LCE3E |
| Interaction | ADAMTSL4 interactions | KRTAP5-9 NTN4 LCE5A DLK2 PLSCR1 KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-8 | 4.73e-10 | 217 | 57 | 10 | int:ADAMTSL4 |
| Interaction | CREB5 interactions | KRTAP5-9 SPRY3 CNFN LCE5A KRTAP10-1 LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-8 | 8.08e-10 | 164 | 57 | 9 | int:CREB5 |
| Interaction | KRTAP10-9 interactions | KRTAP5-9 LCE5A PLSCR1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.31e-09 | 241 | 57 | 10 | int:KRTAP10-9 |
| Interaction | NUFIP2 interactions | KRTAP5-9 NELL1 CRELD1 LCE5A VWCE PLSCR1 KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.61e-09 | 417 | 57 | 12 | int:NUFIP2 |
| Interaction | NKD1 interactions | 2.97e-09 | 21 | 57 | 5 | int:NKD1 | |
| Interaction | GLRX3 interactions | KRTAP5-9 NTRK1 LMTK3 PLSCR1 KRT38 KRTAP10-1 LCE2D KRTAP10-11 KRTAP10-8 | 3.10e-09 | 191 | 57 | 9 | int:GLRX3 |
| Interaction | ZNF587 interactions | KRTAP5-9 SPRY3 PLSCR1 KRT38 KRTAP10-1 KRTAP10-11 KRTAP10-7 KRTAP10-8 | 4.12e-09 | 135 | 57 | 8 | int:ZNF587 |
| Interaction | KRTAP10-6 interactions | 5.26e-09 | 88 | 57 | 7 | int:KRTAP10-6 | |
| Interaction | CHRD interactions | 8.37e-09 | 94 | 57 | 7 | int:CHRD | |
| Interaction | OTX1 interactions | KRTAP5-9 KRTAP17-1 KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.23e-08 | 155 | 57 | 8 | int:OTX1 |
| Interaction | KRTAP10-8 interactions | KRTAP5-9 NTN4 LCE5A KRTAP17-1 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.37e-08 | 401 | 57 | 11 | int:KRTAP10-8 |
| Interaction | POM121L8P interactions | 1.87e-08 | 11 | 57 | 4 | int:POM121L8P | |
| Interaction | KRTAP12-1 interactions | 2.34e-08 | 63 | 57 | 6 | int:KRTAP12-1 | |
| Interaction | NPDC1 interactions | 2.84e-08 | 65 | 57 | 6 | int:NPDC1 | |
| Interaction | DOCK2 interactions | 3.11e-08 | 66 | 57 | 6 | int:DOCK2 | |
| Interaction | CRCT1 interactions | 3.11e-08 | 66 | 57 | 6 | int:CRCT1 | |
| Interaction | ZNF696 interactions | 3.73e-08 | 68 | 57 | 6 | int:ZNF696 | |
| Interaction | KRTAP1-3 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-8 | 4.68e-08 | 184 | 57 | 8 | int:KRTAP1-3 |
| Interaction | CHIC2 interactions | 5.74e-08 | 73 | 57 | 6 | int:CHIC2 | |
| Interaction | MAPKBP1 interactions | 6.24e-08 | 74 | 57 | 6 | int:MAPKBP1 | |
| Interaction | ZNF440 interactions | 9.23e-08 | 40 | 57 | 5 | int:ZNF440 | |
| Interaction | KRTAP10-7 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.25e-07 | 293 | 57 | 9 | int:KRTAP10-7 |
| Interaction | CYSRT1 interactions | KRTAP5-9 NTN4 LCE5A C11orf16 KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.61e-07 | 511 | 57 | 11 | int:CYSRT1 |
| Interaction | KRTAP1-1 interactions | KRTAP5-9 LCE5A KRTAP10-1 LCE2D LCE2C LCE3B KRTAP10-11 KRTAP10-8 | 1.79e-07 | 219 | 57 | 8 | int:KRTAP1-1 |
| Interaction | TRIM42 interactions | 2.03e-07 | 149 | 57 | 7 | int:TRIM42 | |
| Interaction | ZNF138 interactions | 2.16e-07 | 19 | 57 | 4 | int:ZNF138 | |
| Interaction | SPRY2 interactions | 2.33e-07 | 152 | 57 | 7 | int:SPRY2 | |
| Interaction | NBPF19 interactions | KRTAP5-9 NTN4 LCE5A KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-8 | 2.87e-07 | 233 | 57 | 8 | int:NBPF19 |
| Interaction | VASN interactions | 3.30e-07 | 160 | 57 | 7 | int:VASN | |
| Interaction | FAM76B interactions | 3.57e-07 | 99 | 57 | 6 | int:FAM76B | |
| Interaction | GNE interactions | 4.79e-07 | 104 | 57 | 6 | int:GNE | |
| Interaction | NTN4 interactions | 4.89e-07 | 23 | 57 | 4 | int:NTN4 | |
| Interaction | ZNF581 interactions | 7.04e-07 | 111 | 57 | 6 | int:ZNF581 | |
| Interaction | VWC2 interactions | 8.66e-07 | 62 | 57 | 5 | int:VWC2 | |
| Interaction | KRTAP10-10 interactions | 9.61e-07 | 27 | 57 | 4 | int:KRTAP10-10 | |
| Interaction | ZNF439 interactions | 9.61e-07 | 27 | 57 | 4 | int:ZNF439 | |
| Interaction | NOTCH2NLA interactions | KRTAP5-9 NTN4 LCE5A KRTAP10-1 LCE2D LCE2C KRTAP10-11 KRTAP10-7 KRTAP10-8 | 1.13e-06 | 381 | 57 | 9 | int:NOTCH2NLA |
| Interaction | KRTAP5-7 interactions | 1.71e-06 | 71 | 57 | 5 | int:KRTAP5-7 | |
| Interaction | ZNF101 interactions | 2.21e-06 | 33 | 57 | 4 | int:ZNF101 | |
| Interaction | BCL6B interactions | 2.21e-06 | 33 | 57 | 4 | int:BCL6B | |
| Interaction | SLC6A20 interactions | 2.50e-06 | 34 | 57 | 4 | int:SLC6A20 | |
| Interaction | WNT11 interactions | 2.82e-06 | 35 | 57 | 4 | int:WNT11 | |
| Interaction | ZNF408 interactions | 3.35e-06 | 145 | 57 | 6 | int:ZNF408 | |
| Interaction | KRTAP12-3 interactions | 3.49e-06 | 146 | 57 | 6 | int:KRTAP12-3 | |
| Interaction | DMRT3 interactions | 4.68e-06 | 87 | 57 | 5 | int:DMRT3 | |
| Interaction | HPCAL1 interactions | 4.96e-06 | 88 | 57 | 5 | int:HPCAL1 | |
| Interaction | ZNF264 interactions | 5.39e-06 | 41 | 57 | 4 | int:ZNF264 | |
| Interaction | ZBTB24 interactions | 5.71e-06 | 159 | 57 | 6 | int:ZBTB24 | |
| Interaction | NECTIN2 interactions | 5.71e-06 | 159 | 57 | 6 | int:NECTIN2 | |
| Interaction | BRME1 interactions | 7.17e-06 | 44 | 57 | 4 | int:BRME1 | |
| Interaction | ZNF20 interactions | 7.17e-06 | 44 | 57 | 4 | int:ZNF20 | |
| Interaction | KRTAP2-3 interactions | 7.22e-06 | 95 | 57 | 5 | int:KRTAP2-3 | |
| Interaction | SHFL interactions | 8.00e-06 | 97 | 57 | 5 | int:SHFL | |
| Interaction | ZNF266 interactions | 9.53e-06 | 15 | 57 | 3 | int:ZNF266 | |
| Interaction | C10orf62 interactions | 9.53e-06 | 15 | 57 | 3 | int:C10orf62 | |
| Interaction | ZNF625 interactions | 9.53e-06 | 15 | 57 | 3 | int:ZNF625 | |
| Interaction | KRTAP2-4 interactions | 9.74e-06 | 101 | 57 | 5 | int:KRTAP2-4 | |
| Interaction | KRTAP1-5 interactions | 1.02e-05 | 48 | 57 | 4 | int:KRTAP1-5 | |
| Interaction | AVPI1 interactions | 1.02e-05 | 48 | 57 | 4 | int:AVPI1 | |
| Cytoband | 21q22.3 | KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 1.67e-08 | 128 | 59 | 6 | 21q22.3 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 9.20e-06 | 377 | 59 | 6 | chr21q22 |
| Cytoband | 1q21.3 | 1.64e-05 | 117 | 59 | 4 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.74e-04 | 404 | 59 | 5 | chr1q21 | |
| Cytoband | 17q12-q21 | 7.86e-04 | 32 | 59 | 2 | 17q12-q21 | |
| GeneFamily | Keratin associated proteins | KRTAP5-9 KRTAP17-1 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 8.81e-11 | 109 | 40 | 8 | 619 |
| GeneFamily | Late cornified envelope proteins | 6.14e-08 | 18 | 40 | 4 | 627 | |
| GeneFamily | Insulin like growth factor binding proteins | 7.12e-05 | 6 | 40 | 2 | 1065 | |
| GeneFamily | CYR61/CTGF/NOV matricellular proteins | 7.12e-05 | 6 | 40 | 2 | 1046 | |
| GeneFamily | Laminin subunits | 3.11e-04 | 12 | 40 | 2 | 626 | |
| GeneFamily | Abhydrolase domain containing | 1.07e-03 | 22 | 40 | 2 | 4 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.53e-03 | 40 | 40 | 2 | 321 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CCN6 NELL1 CRELD1 NTN4 LAMB4 FRAS1 IGFBP2 IGFBP4 CCN1 KCP CRELD2 LAMA5 BMPER VWCE SSPOP | 9.22e-20 | 196 | 56 | 15 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 CCN6 NELL1 CRELD1 NTN4 LAMB4 FRAS1 IGFBP2 IGFBP4 CCN1 KCP CRELD2 LAMA5 BMPER VWCE SSPOP | 3.98e-19 | 275 | 56 | 16 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CCN6 NELL1 CRELD1 NTN4 FRAS1 IGFBP2 IGFBP4 CCN1 KCP CRELD2 LAMA5 BMPER VWCE SSPOP | 3.26e-18 | 191 | 56 | 14 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 CCN6 NELL1 CRELD1 NTN4 FRAS1 IGFBP2 IGFBP4 CCN1 KCP CRELD2 LAMA5 BMPER VWCE SSPOP | 1.18e-17 | 270 | 56 | 15 | MM17057 |
| Coexpression | NABA_MATRISOME | COL4A4 CCN6 NELL1 CRELD1 NTN4 LAMB4 FRAS1 IGFBP2 IGFBP4 CCN1 TIMP1 KCP CRELD2 LAMA5 BMPER VWCE SSPOP | 2.42e-11 | 1026 | 56 | 17 | M5889 |
| Coexpression | NABA_MATRISOME | COL4A4 CCN6 NELL1 CRELD1 NTN4 FRAS1 IGFBP2 IGFBP4 CCN1 TIMP1 KCP CRELD2 LAMA5 BMPER VWCE SSPOP | 2.00e-10 | 1008 | 56 | 16 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.61e-06 | 40 | 56 | 4 | M5887 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS | 5.40e-06 | 118 | 56 | 5 | M40281 | |
| Coexpression | MACLACHLAN_BRCA1_TARGETS_UP | 1.20e-05 | 21 | 56 | 3 | M17772 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 | 3.60e-05 | 30 | 56 | 3 | MM835 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 4.09e-05 | 440 | 56 | 7 | M39039 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | ABHD17A IGFBP2 IGFBP4 CCN1 TIMP1 PROSER2 IL4R PLSCR1 ARHGEF15 | 1.02e-04 | 888 | 56 | 9 | M39049 |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_ONLY_DN | 1.15e-04 | 44 | 56 | 3 | M1316 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_ONLY_DN | 1.15e-04 | 44 | 56 | 3 | MM1128 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 1.59e-04 | 49 | 56 | 3 | MM452 | |
| Coexpression | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP | 2.25e-04 | 258 | 56 | 5 | M4680 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | 2.28e-04 | 775 | 56 | 8 | M45713 | |
| Coexpression | DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS | 2.57e-04 | 144 | 56 | 4 | M40230 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL | 2.92e-04 | 12 | 56 | 2 | M45774 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 2.92e-04 | 12 | 56 | 2 | M17374 | |
| CoexpressionAtlas | skin | 1.10e-07 | 456 | 51 | 10 | skin | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 6.98e-07 | 426 | 51 | 9 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | LRIG3 NTN4 MT3 NTRK1 RHOBTB3 KCP BMPER SSPOP PLSCR1 ARHGEF15 SORCS1 | 1.70e-05 | 982 | 51 | 11 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 7.33e-05 | 761 | 51 | 9 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP5-9 KRTAP17-1 KRT38 KRTAP10-1 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-8 | 2.89e-13 | 146 | 58 | 9 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 195 | 58 | 6 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-07 | 199 | 58 | 6 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.17e-06 | 142 | 58 | 5 | 77fd145c1c500d580f70ac4e54c3fd879ecf0ab3 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-06 | 152 | 58 | 5 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.67e-06 | 168 | 58 | 5 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.75e-06 | 169 | 58 | 5 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.75e-06 | 169 | 58 | 5 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 3.64e-06 | 179 | 58 | 5 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-06 | 181 | 58 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-06 | 186 | 58 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-D-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-06 | 188 | 58 | 5 | 50481192da0e9484accb7fcbf9e28a246bb3b80f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-D|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-06 | 188 | 58 | 5 | 30bbd00297de7a2e3e6008aaf37ec0d0617315eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-06 | 188 | 58 | 5 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.12e-06 | 192 | 58 | 5 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.12e-06 | 192 | 58 | 5 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 192 | 58 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.52e-06 | 195 | 58 | 5 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-06 | 196 | 58 | 5 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 5.66e-06 | 196 | 58 | 5 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-06 | 196 | 58 | 5 | d688350aadc622984d612ae6b2fd7c0113a4ec0f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-06 | 197 | 58 | 5 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-06 | 197 | 58 | 5 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.81e-06 | 197 | 58 | 5 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.95e-06 | 198 | 58 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.95e-06 | 198 | 58 | 5 | e0ef49ec0f87cc87b45efa297b9ff6c35b7a2ba9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-06 | 198 | 58 | 5 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | normal_Pleural_Fluid-Epithelial_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.10e-06 | 199 | 58 | 5 | 564ba7acd03be2d6e4d0850cb2c7237a788dc275 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-06 | 200 | 58 | 5 | 4c20102de2ff7a38e5bff5c65e9fbd0d0310a302 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-06 | 200 | 58 | 5 | ae91dc047dc80560ba298d8d21a772154fa2775d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-06 | 200 | 58 | 5 | ac5843142e0f8a5bcd2c3a784ea13b2f955a32fd | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.25e-06 | 200 | 58 | 5 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.08e-05 | 105 | 58 | 4 | 744be8b4255bef3a973db7e4306e52387852e502 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-05 | 53 | 58 | 3 | 5fa009c9f30c77de6cece40a47da46241f1de54c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-05 | 53 | 58 | 3 | 52a1f2a041e3ba2b11ed753f2f57b78e68b5cc0c | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.85e-05 | 154 | 58 | 4 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 157 | 58 | 4 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.77e-05 | 161 | 58 | 4 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.19e-05 | 164 | 58 | 4 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 166 | 58 | 4 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 166 | 58 | 4 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.96e-05 | 169 | 58 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 8d3c51364a332020810836e2055c60893c10d7f3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 172 | 58 | 4 | 5401ac7739f95fb8681cfb4747ab6e447a3c2ae8 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 172 | 58 | 4 | b3da7f488d191214d7bb74fbac189fe8c29ee6cd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 172 | 58 | 4 | 74dd4a7acb2cf857fed20219e4d7dc1adfbaa398 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.79e-05 | 174 | 58 | 4 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 174 | 58 | 4 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.79e-05 | 174 | 58 | 4 | b31a6c9d8f7c8cb229c0539d959c19251e2fcd13 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.14e-05 | 176 | 58 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.14e-05 | 176 | 58 | 4 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 8.32e-05 | 177 | 58 | 4 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.32e-05 | 177 | 58 | 4 | 8c6d8a1c469346e66f9095d86b4615f8fc611362 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 8.32e-05 | 177 | 58 | 4 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 177 | 58 | 4 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 177 | 58 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-05 | 178 | 58 | 4 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.51e-05 | 178 | 58 | 4 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-05 | 178 | 58 | 4 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.69e-05 | 179 | 58 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.69e-05 | 179 | 58 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.88e-05 | 180 | 58 | 4 | 255097d8eb244a32eb2ecd0e7e48e1a20bafb5cd | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 180 | 58 | 4 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-05 | 180 | 58 | 4 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.07e-05 | 181 | 58 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-05 | 181 | 58 | 4 | dae0d106f0eee5dba538617f8ed724925ea35f17 | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 9.07e-05 | 181 | 58 | 4 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-05 | 182 | 58 | 4 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.27e-05 | 182 | 58 | 4 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-05 | 182 | 58 | 4 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.27e-05 | 182 | 58 | 4 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 9.47e-05 | 183 | 58 | 4 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 183 | 58 | 4 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 9.47e-05 | 183 | 58 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-05 | 183 | 58 | 4 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-05 | 183 | 58 | 4 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-05 | 183 | 58 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 183 | 58 | 4 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.67e-05 | 184 | 58 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.67e-05 | 184 | 58 | 4 | 157a3d00165bb4a8c52c3e63ae57d9cf57500be7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.87e-05 | 185 | 58 | 4 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 74b787e225d83efcb84e79c23499febe1a106622 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.87e-05 | 185 | 58 | 4 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.87e-05 | 185 | 58 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | d1cfca6e85fa767253de7e8a14621989b816635f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 186 | 58 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-04 | 187 | 58 | 4 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 187 | 58 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 187 | 58 | 4 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 187 | 58 | 4 | f6ea69360dca9839ddaaaaca26a7dbb570d23262 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 187 | 58 | 4 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 187 | 58 | 4 | db771e952f71a12886c2dbc77c6cd07054ef809a | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.05e-04 | 188 | 58 | 4 | de7cb273899d0e0748c85f45c6b5e7f0642ab057 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 188 | 58 | 4 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.05e-04 | 188 | 58 | 4 | f4734d5b703678670ece204a0519cf015e180a6e | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| Computational | Placenta genes. | 8.47e-05 | 463 | 26 | 7 | MODULE_38 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | IGFBPs. | 3.66e-04 | 12 | 26 | 2 | MODULE_190 | |
| Computational | Trachea genes. | 3.81e-04 | 415 | 26 | 6 | MODULE_6 | |
| Computational | Genes in the cancer module 474. | 7.48e-04 | 17 | 26 | 2 | MODULE_474 | |
| Computational | Ovary genes. | 1.66e-03 | 368 | 26 | 5 | MODULE_1 | |
| Drug | Rgd Peptide | 2.18e-06 | 239 | 57 | 7 | CID000104802 | |
| Disease | Cholangitis | 4.97e-05 | 7 | 46 | 2 | C0008311 | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 1.83e-04 | 13 | 46 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | erythritol measurement | 3.19e-04 | 17 | 46 | 2 | EFO_0021171 | |
| Disease | hair morphology | 9.40e-04 | 29 | 46 | 2 | EFO_0005038 | |
| Disease | asthma (implicated_via_orthology) | 1.37e-03 | 35 | 46 | 2 | DOID:2841 (implicated_via_orthology) | |
| Disease | Autoimmune Diseases | 1.97e-03 | 42 | 46 | 2 | C0004364 | |
| Disease | Respiratory Distress Syndrome, Adult | 3.35e-03 | 55 | 46 | 2 | C0035222 | |
| Disease | polyp of colon | 3.47e-03 | 56 | 46 | 2 | MONDO_0021400 | |
| Disease | atopic asthma | 3.71e-03 | 199 | 46 | 3 | EFO_0010638 | |
| Disease | pyroglutamine measurement | 3.72e-03 | 58 | 46 | 2 | EFO_0005408 | |
| Disease | methadone dose measurement | 4.24e-03 | 62 | 46 | 2 | EFO_0007907 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CTCIDGAVGCIPLCP | 121 | O00622 | |
| PKYCGSCVDGRCCTP | 311 | O00622 | |
| PCGGRDCSVCHCVPE | 46 | P53420 | |
| LSELCCLFCCPPCPG | 6 | Q96GS6 | |
| DAGLACPPCCPCVCH | 201 | O94989 | |
| CGSLGDCPPPPCCCS | 541 | O95153 | |
| LCCPAGTFGPSCLPC | 141 | Q96HD1 | |
| CSACFGPCARCSGPE | 211 | Q96HD1 | |
| CPDACCPHGSSGLRC | 36 | P04629 | |
| GSCCPVCVGLGKPCS | 146 | Q86XX4 | |
| PCPTTCRCLGDLLDC | 46 | Q6UXM1 | |
| SCGPCTTCGPTCGAS | 436 | O76015 | |
| PLPCPLCSREGACSC | 666 | Q96Q04 | |
| CPAPCSCAGTLVDCG | 26 | P13224 | |
| SGPCVVCSCCGDVDF | 231 | O15162 | |
| EPGCGCCSVCARLEG | 81 | P18065 | |
| GPTCERCPTCGDPCN | 611 | P18564 | |
| SGCPPGKCVCNSCGL | 66 | Q68G74 | |
| LPGNCTRCDCTPCGT | 2016 | O15230 | |
| CNCPPGLSGERCDTC | 2131 | O15230 | |
| CPCPSGGSCTCADSC | 6 | P25713 | |
| DCLCPSGPSCSGDCP | 621 | Q92832 | |
| CPPGVSLVRDGCGCC | 61 | O95389 | |
| TPVMASPCCGCCCGD | 736 | P24394 | |
| SPCCGCCCGDRSSPP | 741 | P24394 | |
| LGMCCPTCPGCVFEG | 156 | Q8N8U9 | |
| TPAVCEGPCVEGCQC | 3176 | Q9Y6R7 | |
| PPSGSEARCCCCACK | 11 | Q9H972 | |
| CGPPCTFWPCFELCC | 66 | Q6UWQ7 | |
| CLCDPVTGACPCLPN | 1041 | A4D0S4 | |
| PICCVPVCSGASTSC | 196 | P60331 | |
| CGTPSCCAPAPCLTL | 31 | P60368 | |
| VCKSTCCVPVPSCGA | 311 | P60371 | |
| CCVPVPSCGASASSC | 316 | P60371 | |
| CKPVCCVPVCSGAST | 271 | P60409 | |
| PVCCVSICSGASSPC | 131 | P60410 | |
| CKPICCVPVCSGASS | 171 | P60410 | |
| KPVCCVPVCCGAASS | 111 | P60412 | |
| SGCRGCGPSCCAPVY | 26 | P26371 | |
| SCCGPSSGSCCGPSS | 46 | Q5TA81 | |
| SCCGPSSGSCCGPSS | 46 | Q5TA82 | |
| CCAPRPGCCGGPSSE | 36 | Q5TA77 | |
| PPVSSCCGSSSGGCC | 46 | Q5TCM9 | |
| PSCCVSSCCISGFGG | 41 | P0DV60 | |
| CGSGCCGPVCCQPTP | 86 | Q9BYP8 | |
| CPFEKCCSTEPCLSG | 101 | Q9H2J1 | |
| AHGCCAPDGSCRCDP | 36 | Q6UY11 | |
| VCCSPGTYGPDCLAC | 126 | Q6UXH1 | |
| LPCTCPLCTSDRGSC | 141 | O94955 | |
| CPLDCSGPVCPAFCF | 716 | Q7Z4K8 | |
| AAVCGCDPGSDCLCP | 786 | A2VEC9 | |
| GIECTGFCAPGCTCP | 2916 | A2VEC9 | |
| CRPCDCAGSCDPITG | 446 | Q9HB63 | |
| LCDGGVCCLCSPSLE | 81 | Q86WR7 | |
| PLPGTCCPNDCSGCA | 591 | Q6ZWJ8 | |
| CACGPGSSADACLCD | 1441 | Q6ZWJ8 | |
| GRCAVLGLCCSPDGC | 96 | P01178 | |
| ELVREPGCGCCATCA | 46 | P22692 | |
| CADEPCSCGPSSCFV | 206 | O43610 | |
| FSELCCLFCCPPCPG | 6 | Q5VST6 | |
| PVCLCGTFAPLCLAC | 36 | Q9BYD5 | |
| LLCQGCLCGCPPCGT | 276 | Q9NQ32 | |
| VGGGEPCAAPCCCLP | 286 | Q9Y242 | |
| GCEECTVFPCLSIPC | 146 | P01033 | |
| PASDLCTCVTCCSGP | 36 | Q6XCG6 | |
| CTLPLCSFGCGSGIC | 66 | Q96DN2 | |
| RIPGQCCPDCSAGCT | 616 | Q96DN2 | |
| LPSPALCCACGLCAL | 26 | A0A0U1RQS6 | |
| LCAPGVCGGGSCCPS | 26 | Q8WY21 |